Professor Peter Horby
Research on emerging infectious diseases can only be conducted during outbreaks. Although virology has improved, a well calibrated and effective public health response is often lacking. Epidemiological and clinical research as well as mathematical modelling will give us answers during the epidemics and help us provide better diagnostics and better treatments.
Professor of Emerging Infectious Diseases and Global Health
- Group Leader Epidemic diseases Research Group Oxford (ERGO), @Oxford
- Executive Director, ISARIC
Peter Horby is Professor of Emerging Infectious Diseases and Global Health. He is the former, and founding, Director of the Oxford University Clinical Research Unit in Hanoi, Vietnam. The unit was established in early 2006 and conducts research on infectious diseases which crosses the disciplines of basic science, medical science and public health.
Peter returned to Oxford in 2014 and established the Epidemic disease Research Group Oxford (ERGO). ERGO is engaged in an international program of clinical and epidemiological research to prepare for and respond to emerging infections that may develop into epidemics or pandemics. ERGO is involved in a number of international projects including the European Commission funded PREPARE project, and ISARIC (International Severe Acute Respiratory and Emerging Infection Consortium). The group is conducting research on a range of epidemic diseases including Ebola virus disease, bird flu (H5N1 and H7N9), MERS-CoV, and Enterovirus 71. ERGO currently comprises a team of eight people under the leadership of Professor Peter Horby and is funded by Wellcome, the Medical Research Council, and the European Commission.
Influenza in Vietnam
Águas R. et al, (2021), Nature Communications, 12
COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study
Horby P. et al, (2021), Infection
Abani O. et al, (2021), The Lancet, 397, 1637 - 1645
Gupta RK. et al, (2021), The Lancet Respiratory Medicine, 9, 349 - 359
Lassa fever outcomes and prognostic factors in Nigeria (LASCOPE): a prospective cohort study
Horby P. and Salam A., (2021), The Lancet